Back to search
Implantable Cardioverter-defibrillators (ICDs)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Implantable Cardioverter-defibrillators (ICDs) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Implantable Cardioverter-defibrillators (ICDs) trials you may qualify forThe main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-rel…
Role of the implantable cardioverter defibrillator (ICD) is to monitor heart rate and discharge a small electrical discharge or shock if the heart rate becomes…
Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sud…
This study will test an exercise intervention (E-ICD) following an implantable cardioverter defibrillator.
This prospective, multicenter, open-label, randomized-controlled trial compares two treatment strategies in high-risk ischemic cardiomyopathy (ICM) patients ref…
Ventricular arrhythmias are a serious complication of myocardial infarction. The aim of this study is to provide reliable data on the management and mortality a…
While research and clinical practice have demonstrated the objective benefits of pacemaker use on mortality, morbidity, and quality of life, some patients do no…
This is a prospective cohort study of older patients receiving implantable cardioverter-defibrillators. The purpose of the TRACER-ICD study is to conduct a pros…
To compare Treatment Group (settings of Early Multiple ATP) and Control Group (settings of extended detection time for the conventional ATP) in Japanese patient…